financetom
Business
financetom
/
Business
/
Sasol H1 Earnings, Revenue Decrease -- Shares Up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sasol H1 Earnings, Revenue Decrease -- Shares Up Pre-Bell
Feb 24, 2025 3:45 AM

06:16 AM EST, 02/24/2025 (MT Newswires) -- Sasol ( SSL ) reported H1 headline earnings Monday of 14.13 South African rand ($0.77) per share, down from 20.37 rand a year earlier.

One analyst polled by FactSet expected 13.77 rand.

Revenue for the six months ended Dec. 31 was 122.10 billion rand, down from 136.29 billion rand a year earlier.

One analyst surveyed by FactSet expected 122.76 billion rand.

Shares of the South African energy and chemical company were up nearly 6% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google invests in Intersect Power in over $800 mln funding round amid AI race
Google invests in Intersect Power in over $800 mln funding round amid AI race
Dec 10, 2024
Dec 10 (Reuters) - Alphabet's Google, along with TPG Rise Climate and other investors, is backing clean energy developer Intersect Power as part more than $800 million funding round, the company said on Tuesday. Google's capital investment in Intersect Power comes as the tech giant, like other hyperscalers including Microsoft ( MSFT ) and Meta, races to bolster its domestic...
Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test
Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test
Dec 10, 2024
09:03 AM EST, 12/10/2024 (MT Newswires) -- Akoya Biosciences ( AKYA ) said Tuesday that it has signed an exclusive global license agreement with NeraCare to develop and commercialize the Immunoprint test on Akoya's multiplexed immunofluorescent platform. The agreement grants Akoya rights to develop and market the test for clinical research, diagnostic development, or patient testing following regulatory approval, Akoya...
Update: Market Chatter: Boeing Resumes 737-MAX Production
Update: Market Chatter: Boeing Resumes 737-MAX Production
Dec 10, 2024
09:01 AM EST, 12/10/2024 (MT Newswires) -- (Updates to include Boeing's ( BA ) response in the fourth paragraph.) Boeing ( BA ) resumed production of its 737 MAX aircraft last week almost a month after a nearly eight-week strike, Reuters reported Monday, citing three unnamed sources familiar with the matter. Production of the jet resumed on Friday, the report...
Ferguson's Fiscal First-Quarter Earnings Fall Annually as Sales Miss Market Expectations
Ferguson's Fiscal First-Quarter Earnings Fall Annually as Sales Miss Market Expectations
Dec 10, 2024
09:02 AM EST, 12/10/2024 (MT Newswires) -- Ferguson's (FERG) fiscal first-quarter earnings declined on an annual basis and sales fell short of Wall Street estimates amid continued weakness in certain commodity categories while the company reiterated its full-year revenue growth outlook. The UK-based plumbing and heating products company on Tuesday posted adjusted earnings of $2.45 per share, down from $2.65...
Copyright 2023-2025 - www.financetom.com All Rights Reserved